Last Update 15:4
Monday, 11 December 2017

Prescription video games help children with ADHD in trial

Cases of ADHD have been rising around the world in recent decades, with children often given drugs to treat the disorder.

Reuters , Monday 4 Dec 2017
Reuters
Share/Bookmark
Views: 1155
Share/Bookmark
Views: 1155

Playing tailor-made video games can help children with attention deficit hyperactivity disorder (ADHD), according to results from a pivotal clinical trial announced on Monday.

The U.S. company developing the treatment, unlisted Akili, now plans to file for regulatory approval with the U.S. Food and Drug Administration in the first half of 2018, paving the way for what would be the first such “digital” prescription product.

Cases of ADHD have been rising around the world in recent decades, with children often given drugs to treat the disorder. Akili’s product takes a different approach by using a game to stimulate specific cognitive neural systems in the brain.

In the randomized, controlled trial of 348 children and adolescents with ADHD, Akili’s product AKL-T01 showed a statistically significant improvement compared with an active control in attention performance. The control was also a video game.

Medicating ADHD is big business, with Shire a leading player in the field. Shire is also an investor in Akili. 

Short link:

 

Email
 
Name
 
Comment's
Title
 
Comment
Ahram Online welcomes readers' comments on all issues covered by the site, along with any criticisms and/or corrections. Readers are asked to limit their feedback to a maximum of 1000 characters (roughly 200 words). All comments/criticisms will, however, be subject to the following code
  • We will not publish comments which contain rude or abusive language, libelous statements, slander and personal attacks against any person/s.
  • We will not publish comments which contain racist remarks or any kind of racial or religious incitement against any group of people, in Egypt or outside it.
  • We welcome criticism of our reports and articles but we will not publish personal attacks, slander or fabrications directed against our reporters and contributing writers.
  • We reserve the right to correct, when at all possible, obvious errors in spelling and grammar. However, due to time and staffing constraints such corrections will not be made across the board or on a regular basis.
Latest

© 2010 Ahram Online.